A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia. - Mohamed SMA; Schofield P; Evans K; Friedrich KH; Christ D; Bayat N; Lock RB (Leukemia, 2026)